Core Viewpoint - The announcement details the resolutions from the first extraordinary general meeting of shareholders for Ruikang Pharmaceutical Group Co., Ltd. in 2026, including the approval of a change in the accounting firm [1][6]. Group 1: Meeting Notification - The notice for the extraordinary general meeting was disclosed on December 26, 2025, in various financial publications [2]. - The meeting was convened by the company's board of directors and took place on January 12, 2026, at 15:00, using a combination of in-person and online voting [3][8]. Group 2: Attendance and Voting - A total of 909 shareholders and their proxies participated in the voting, representing 231,471,225 shares, which is 15.3831% of the total voting shares [4]. - Among the attendees, one shareholder represented 185,491,897 shares (12.3274%), while 908 participated via online voting, representing 45,979,328 shares (3.0557%) [4]. Group 3: Voting Results - The meeting approved the resolution to change the accounting firm, with 229,745,425 shares in favor, 1,373,700 against, and 352,100 abstentions, translating to 99.2544%, 0.5935%, and 0.1521% of the votes cast, respectively [9]. - For minority shareholders, the voting results were 44,253,528 shares in favor (96.2466%), 1,373,700 against (2.9876%), and 352,100 abstentions (0.7658%) [9]. Group 4: Legal Witness and Documentation - The meeting was witnessed by Shandong Qianyuan Law Firm, which issued a legal opinion confirming that the meeting's procedures and voting results complied with legal and regulatory requirements [10]. - The documents available for review include the resolutions from the meeting and the legal opinion from the law firm [11].
瑞康医药集团股份有限公司2026年第一次临时股东会决议的公告